摘要
随着国家药品谈判进程的加快,谈判药品越来越多,各谈判药品价值有高低,治疗领域存在差异,适用的医保支付政策也有所区别。本文在借鉴部分地区落实国家谈判药品政策的基础上,结合国家谈判药品的特点,为完善各省市国家谈判药品医保支付政策提供一些思考。
With the acceleration of the national drug negotiation process,more and more drugs are negotiated,the value of each negotiated drug,the treatment fi eld and the applicable medical insurance payment policy is different.Based on the implementation of national negotiated drug policies in some regions and the characteristics of national negotiated drugs,this article provides some considerations for the improvement of the medical insurance payment policies of various provinces and cities.
作者
徐伟
陈玲玲
汪宁
何仁鑫
Xu Wei;Chen Lingling;Wang Ning;He Renxin(School of International Pharmaceutical Business,China Pharmaceutical University,Nanjing,211198)
出处
《中国医疗保险》
2020年第6期8-11,共4页
China Health Insurance
基金
2019年国家医疗保障局项目《我国药品与医用耗材的医保支付管理研究》。
关键词
药品谈判
医保支付
待遇水平
negotiated drugs
medical insurance payment
treatment level
